Results 241 to 250 of about 1,075,360 (295)

Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancer. [PDF]

EBioMedicine
Lee P, Abdelhamid K, Butler R, Cooper W, Nagasaka M, Peters S, Seijo L, Silvestri G, Wee B, Yasufuku K, Navani N.   +10 more
europepmc   +1 more source

Engineered Mesenchymal Stem Cell–NK Cell Complexes for Spatially Targeted and Functionally Revitalized Cancer Immunotherapy

Advanced Science, EarlyView.
IL‐15‐engineered stem cell–NK cell complexes, assembled via bioorthogonal chemistry, enable effective lung cancer immunotherapy. Abstract Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation.
Qian Zhang, Bo Yin, Munaiwaier Sabier, Youlan Yang, Mengling Wu, Zhouping Zhao, Xuanzhi Luo, Yuehong Zhong, Xiuming Zhu, Jie Zhang, Jing Wang, Kai Chen, Fei Ruan, Wei Zhang, Zhimin Lu, Jiong Wang   +15 more
wiley   +1 more source

Statewide Medicaid Expansion and Survival in Resectable Non-Small Cell Lung Cancer. [PDF]

JAMA Netw Open
Gawdi R, Islam S, Sha C, Liu S, Glassman LR, Hyman KM, Jurado JE, Zeltsman D, Lee PC.   +8 more
europepmc   +1 more source

LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1

Advanced Science, EarlyView.
LMO7 in tumor‐associated macrophages suppresses phagocytosis of tumor cells and limits cytotoxic T lymphocytes infiltration, fostering tumor progression. Mechanistically, LMO7 mediates the ubiquitination and degradation of the phagocytic receptor LRP1, impairing its ability to engulf tumor cells and driving macrophages toward an antitumor phenotype ...
Mengkai Li, Tao Wang, Yuwen Zhong, Zhiming Wang, Wei Li, Zejian Wang, Xinyi Yang, Yu Qiao, Jianfeng Xiang, Wei Gu, Zishu Wang, Lei Sun, Feng Qian   +12 more
wiley   +1 more source

Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer. [PDF]

Front Immunol
Guo H, Xu Z, Li K, Guo C, Lin F, Pu Q, Wang G.   +6 more
europepmc   +1 more source

Non-viral gene delivery for non-small cell lung cancer. [PDF]

Ann Transl Med
Fung V, Gill NA, Andersen S, Fenton OS.
europepmc   +1 more source

The relationship between genetic mutations and organ metastasis in non-small cell lung cancer. [PDF]

Ther Adv Med Oncol
Xue H, Chen Y, Qi F, Chen K, Liu X, Zhang M, Gao Z, Cai S, Gao T, Zhang T.   +9 more
europepmc   +1 more source

Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD Study. [PDF]

Oncol Res
Cheng S, Kordbacheh T, Banyard A, Chaturvedi A, Sanchez Martinez D, Hiley CT, Harris M, Chan C, Faivre-Finn C, Illidge TM, Cheadle EJ.   +10 more
europepmc   +1 more source

Cemiplimab in Japanese patients with advanced non-small cell lung cancer. [PDF]

Jpn J Clin Oncol
Sato Y, Tani Y, Ishii H, Katakura S, Oki M, Watanabe Y, Yokoyama T, Naoki K, Pouliot JF, Kaul M, Paccaly A, Visich JE, Kim E, Mani J, Li Y, Lowy I, Seebach F, Mathias M, Ikeda S.   +18 more
europepmc   +1 more source